The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor 13-dependent apoptosis in breast cancer

Mara H. Rendi, Nanjoo Suh, William W. Lamph, Stan Krajewski, John C. Reed, Richard A. Heyman, Andrew Berchuck, Karen Liby, Renee Risingsong, Darlene B. Royce, Charlotte R. Williams, Michael B. Sporn

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor 13-dependent apoptosis in breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences